Position in NVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$49,194,053
-$46,398,938 QoQ
Shares Held
322,056
-53.6% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
16 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Sep 30, 2025CallValue
$51,296
CallShares
400
PutValue
$89,768
PutShares
700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $2,860,542,672 across 13 Drug Manufacturers - General names. NVS ranks #10 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,377,822 | $581,234,808 | |
| 2 | LLY |
ELI LILLY & Co
|
576,174 | $529,947,557 | |
| 3 | PFE |
Pfizer Inc
|
16,082,788 | $451,604,686 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,778,301 | $334,201,827 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,310,515 | $322,016,474 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,689,838 | $223,788,674 | |
| 7 | NVO |
Novo Nordisk A S
|
3,046,611 | $111,962,952 | |
| 8 | AMGN |
Amgen Inc
|
316,917 | $111,507,246 |
All Filings in NVS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $49,194,053 | 322,056 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $95,592,991 | 693,356 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $149,881,397 | 1,168,757 | Shares | Other | 2025-11-13 | |
| 2025-09-30 | $51,296 | 400 | Call | Other | 2025-11-13 | |
| 2025-09-30 | $89,768 | 700 | Put | Other | 2025-11-13 | |
| 2025-06-30 | $173,263,811 | 1,431,814 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $159,725,756 | 1,432,775 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $8,628,088 | 88,666 | Shares | Other | 2025-02-13 | |
| 2024-03-31 | $12,695,522 | 131,247 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $43,651,552 | 432,322 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $107,670,297 | 1,057,042 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $105,179,703 | 1,042,312 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $122,006,352 | 1,326,156 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $73,872,116 | 814,287 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $66,337,043 | 872,741 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $77,573,096 | 917,699 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $59,552,502 | 678,661 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $13,625,463 | 155,773 | Shares | Other | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||